Awarded
6505--COVID-19 Convalescent Plasma
Awarded tounder 36C24E20D0027 (source: SAM.gov award notice)• $0
Overview
- Posted
- August 19, 2020
- Notice type
- Award Notice
Notice details
- Last updated
- Apr 29, 2026
- Award date
- Aug 19, 2020
- Award amount (SAM.gov award notice)
- $0
Identifiers
- Solicitation number
- 36C24E20Q0202
- Notice ID
- be11f0639d4a4087b641818412a3a3ad
- Award number (PIID)
- 36C24E20D0027
Description
The Department of Veterans Affairs, VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, intends to negotiate on a sole source basis, pursuant to FAR 6.302-1, with Vitalant for national distribution of COVID-19 Convalescent Plasma to provide up to 1200 units of 200mL bags of COVID-19 Convalescent Plasma to support a 24-month VA clinical study using COVID-19 Convalescent Plasma to treat COVID-19 patients. COVID-19 Convalescent Plasma must meet all existing FDA guidelines (subject to change as the COVID-19 Pandemic changes) and come from an approved source. Furthermore, VA-specific requirements limit sources to vendors who can meet International Society of Blood Transfusion (ISBT) format specified in the United States Industry Consensus Standard for the Uniform Labeling of Blood and Blood Components Using ISBT 128 requirements. Vitalant is the only that can provide the plasma meeting all requirements and that can meet the VA requirement for national distribution. This is a notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than Thursday, July 24th, 5:00 PM, EST. Interest/capability statements may be sent to Lynn Portman at lynn.portman@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.
Award Overview
Award Number
36C24E20D0027
Award Amount (SAM.gov award notice)
$0
Award Date
Aug 19, 2020
Awardee
Awardee UEI
GKT4L2JZJ622
Awardee CAGE Code
42091
Original Solicitation
Notice ID: be11f0639d4a4087b641818412a3a3ad
Posted Date: Aug 19, 2020
Original Response Deadline: Not specified
Task Orders Under This IDV
Top 10 by total obligated
- $825.3KSigned Aug 19, 2020
- $809.4KSigned Aug 19, 2025
More From This Vendor
Top 5 most recent
- $63.7KSigned Nov 18, 2026
- $85.9KSigned Nov 8, 2026
- $896.0KSigned Oct 14, 2026
- $2.1MSigned Oct 7, 2026
- $385.9KSigned Oct 6, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24E20Q0202- Solicitation
- Awarded
This opportunity has been awarded.
- Special NoticeJul 16, 2020
6505--Intent to sole source: COVID-19 Convalescent Plasma
- SolicitationJul 28, 2020
6505--Intent to sole source: COVID-19 Convalescent Plasma
- AwardedCurrentAug 19, 2020
6505--COVID-19 Convalescent Plasma
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24E20Q0202
Archive Date
Nov 26, 2020
Office Address
PITTSBURGH, PA, 15212